ANN-MARIE RUSSELL: Open Payments
NPI 1740745918 · KING GEORGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,374 in 77 payments from 23 companies in 2025. Trend: 2023 $2,864 · 2024 $2,465 · 2025 $2,374
Food & beverage: $2,275Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $437 |
| ANI Pharmaceuticals, Inc. | 8 | $253 |
| GlaxoSmithKline, LLC. | 10 | $226 |
| Actelion Pharmaceuticals US, Inc. | 6 | $178 |
| GENZYME CORPORATION | 7 | $167 |
| Pulmonx Corporation | 1 | $167 |
| Lilly USA, LLC | 1 | $122 |
| Amgen Inc. | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
Products named: DUPIXENT, PURIFIED CORTROPHIN GEL, TEZSPIRE, AIRSUPRA, CHARTIS CATHETER, OPSUMIT, ZEPBOUND, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
